Fig. 1
From: Need to continue or discontinue RAS inhibitors as CKD stage advances? Any alternative?
Favorable and unfavorable effects of RAS blockade on advanced CKD patients, and potential benefit of ARNI and SGLT2i
Fig. 1 | Hypertension Research
From: Need to continue or discontinue RAS inhibitors as CKD stage advances? Any alternative?
Favorable and unfavorable effects of RAS blockade on advanced CKD patients, and potential benefit of ARNI and SGLT2i
